These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacokinetics of ceftriaxone in neonates and infants with meningitis. Martin E; Koup JR; Paravicini U; Stoeckel K J Pediatr; 1984 Sep; 105(3):475-81. PubMed ID: 6088747 [TBL] [Abstract][Full Text] [Related]
4. Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment. Patel IH; Sugihara JG; Weinfeld RE; Wong EG; Siemsen AW; Berman SJ Antimicrob Agents Chemother; 1984 Apr; 25(4):438-42. PubMed ID: 6329080 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose. McNamara PJ; Stoeckel K; Ziegler WH Eur J Clin Pharmacol; 1982; 22(1):71-5. PubMed ID: 6284519 [TBL] [Abstract][Full Text] [Related]
6. Single-dose pharmacokinetics of ceftriaxone in infants and young children. Schaad UB; Stoeckel K Antimicrob Agents Chemother; 1982 Feb; 21(2):248-53. PubMed ID: 6280597 [TBL] [Abstract][Full Text] [Related]
7. Cefotaxime and desacetyl cefotaxime kinetics in renal impairment. Matzke GR; Abraham PA; Halstenson CE; Keane WF Clin Pharmacol Ther; 1985 Jul; 38(1):31-6. PubMed ID: 4006373 [TBL] [Abstract][Full Text] [Related]
9. Ceftriaxone pharmacokinetics in newborn infants. McCracken GH; Siegel JD; Threlkeld N; Thomas M Antimicrob Agents Chemother; 1983 Feb; 23(2):341-3. PubMed ID: 6301369 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults. Pollock AA; Tee PE; Patel IH; Spicehandler J; Simberkoff MS; Rahal JJ Antimicrob Agents Chemother; 1982 Nov; 22(5):816-23. PubMed ID: 6295268 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of ceftriaxone in humans. Patel IH; Chen S; Parsonnet M; Hackman MR; Brooks MA; Konikoff J; Kaplan SA Antimicrob Agents Chemother; 1981 Nov; 20(5):634-41. PubMed ID: 6275779 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding model. Stoeckel K; Koup JR Am J Med; 1984 Oct; 77(4C):26-32. PubMed ID: 6093514 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic profile of ceftriaxone in man. Patel IH; Kaplan SA Am J Med; 1984 Oct; 77(4C):17-25. PubMed ID: 6093513 [TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone--clinical experience in the treatment of neonates. James J; Mulhall A; de Louvois J J Infect; 1985 Jul; 11(1):25-33. PubMed ID: 4031525 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of cefotaxime in newborn infants. McCracken GH; Threlkeld NE; Thomas ML Antimicrob Agents Chemother; 1982 Apr; 21(4):683-4. PubMed ID: 6282216 [TBL] [Abstract][Full Text] [Related]
18. Kinetic disposition of intravenous ceftriaxone in normal subjects and patients with renal failure on hemodialysis or peritoneal dialysis. Ti TY; Fortin L; Kreeft JH; East DS; Ogilvie RI; Somerville PJ Antimicrob Agents Chemother; 1984 Jan; 25(1):83-7. PubMed ID: 6322683 [TBL] [Abstract][Full Text] [Related]
19. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination. Ings RM; Reeves DS; White LO; Bax RP; Bywater MJ; Holt HA J Pharmacokinet Biopharm; 1985 Apr; 13(2):121-42. PubMed ID: 4057054 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of ceftriaxone in liver-transplant recipients. Toth A; Abdallah HY; Venkataramanan R; Teperman L; Halsf G; Rabinovitch M; Burckart GJ; Starzl TE J Clin Pharmacol; 1991 Aug; 31(8):722-8. PubMed ID: 1880231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]